147 related articles for article (PubMed ID: 32339215)
21. Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection.
Rodrigues CIS
J Bras Nefrol; 2020 Aug; 42(2 suppl 1):47-48. PubMed ID: 32877500
[TBL] [Abstract][Full Text] [Related]
22. Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.
Ruilope LM; Tamargo J; Ruiz-Hurtado G
Eur Heart J; 2020 Jun; 41(22):2067-2069. PubMed ID: 32498078
[No Abstract] [Full Text] [Related]
23. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Pranata R; Permana H; Huang I; Lim MA; Soetedjo NNM; Supriyadi R; Soeroto AY; Alkatiri AA; Firman D; Lukito AA
Diabetes Metab Syndr; 2020; 14(5):983-990. PubMed ID: 32615377
[TBL] [Abstract][Full Text] [Related]
24. Controversial Relationship Between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.
Di Castelnuovo A; De Caterina R; de Gaetano G; Iacoviello L
Hypertension; 2020 Aug; 76(2):312-313. PubMed ID: 32383624
[No Abstract] [Full Text] [Related]
25. Sarcopenia and COVID-19: A Manifold Insight on Hypertension and the Renin Angiotensin System.
Ekiz T; Kara M; Özcan F; Ricci V; Özçakar L
Am J Phys Med Rehabil; 2020 Oct; 99(10):880-882. PubMed ID: 32657817
[No Abstract] [Full Text] [Related]
26. Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
Mackey K; Kansagara D; Vela K
Ann Intern Med; 2020 Sep; 173(5):W87. PubMed ID: 32701362
[No Abstract] [Full Text] [Related]
27. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
Dworakowska D; Grossman AB
J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
[TBL] [Abstract][Full Text] [Related]
28. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
29. Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): A meta-analysis.
Ng JJ; Luo Y; Phua K; Choong AMTL
J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32389782
[No Abstract] [Full Text] [Related]
30. Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
Bloch MJ
J Am Coll Cardiol; 2020 Jul; 76(3):277-279. PubMed ID: 32674791
[TBL] [Abstract][Full Text] [Related]
31. RAAS Inhibitors and Risk of Covid-19.
Strauss MH; Hall AS; Lavie CJ
N Engl J Med; 2020 Nov; 383(20):1992-1993. PubMed ID: 33108105
[No Abstract] [Full Text] [Related]
32. RAAS Inhibitors and Risk of Covid-19.
Islam N; Khunti K; Chowell G
N Engl J Med; 2020 Nov; 383(20):1992. PubMed ID: 33108104
[No Abstract] [Full Text] [Related]
33. Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
Bobkova I; Kamyshova E; Rudenko T; Stavrovskaya E; Moiseev S
Med Hypotheses; 2020 Oct; 143():109888. PubMed ID: 32480248
[No Abstract] [Full Text] [Related]
34. Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?
Liu D; Li YZ; Wu H
J Hypertens; 2020 Jun; 38(6):1191-1192. PubMed ID: 32371813
[No Abstract] [Full Text] [Related]
35. Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome?
Volpe M; Battistoni A
Int J Cardiol; 2020 Dec; 321():150-154. PubMed ID: 32738257
[TBL] [Abstract][Full Text] [Related]
36. RAAS Inhibitors and Risk of Covid-19. Reply.
Reynolds HR; Adhikari S; Iturrate E
N Engl J Med; 2020 Nov; 383(20):1993-1994. PubMed ID: 33108107
[No Abstract] [Full Text] [Related]
37. RAAS Inhibitors and Risk of Covid-19. Reply.
Mancia G; Rea F; Corrao G
N Engl J Med; 2020 Nov; 383(20):1993. PubMed ID: 33108106
[No Abstract] [Full Text] [Related]
38. Children hospitalized for coronavirus disease 2019 (COVID-19): A multicenter retrospective descriptive study.
Zhang B; Liu S; Zhang J; Xiao J; Zhu S; Dong Y; Yuan H; Zhong Q; Yang K; Zou Y; Zhang S
J Infect; 2020 Aug; 81(2):e74-e75. PubMed ID: 32387474
[No Abstract] [Full Text] [Related]
39. Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients.
Pan W; Zhang J; Wang M; Ye J; Xu Y; Shen B; He H; Wang Z; Ye D; Zhao M; Luo Z; Liu M; Zhang P; Gu J; Liu M; Li D; Liu J; Wan J
Hypertension; 2020 Sep; 76(3):732-741. PubMed ID: 32654555
[TBL] [Abstract][Full Text] [Related]
40. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
